semaglutide effect on dopamine GLP-1 was approved as a weight loss drug. Nobody told you it might also be killing your addictions. Friends and people I know GLP-1s have been reporting an entire stream of Dopaminergic signalling in gastrointestinal health

This altered microbiome directly contributes to increased AHR and inflammation, as noted above ( Figure 1 Possible gut microbiome-targeted therapies for obese asthma patients Various options as gut microbiome-targeted therapies in asthmatic patients with obesity have been suggested, such as fecal microbiome transplantation, probiotics, prebiotics, and the prudent use of antibiotics (93)

Incretin based therapies such as GLP-1 receptor agonists have revolutionised management of type 2 diabetes by enhancing insulin secretion, slowing gastric emptying and reducing appetite (Dungan & DeSantis, 2025)

Imagine how good it feels to be in control rather than feeling regretful

doi:10.1016/j.cjca.2020.04.013 AHA

If clinicians advise withholding Ozempic, ensure there's a plan for glycaemic management and resumption post-procedure

While results may vary from person to person, the evidence suggests that Ozempic can be a powerful tool in reducing stubborn belly fat